{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:52:38Z","timestamp":1790999558943,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jinf.2025.106672","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:39:38Z","timestamp":1767080378000},"page":"106672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Butyrylcholinesterase as an overlooked prognostic biomarker of 100-day mortality in non-COVID CAP"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-6180","authenticated-orcid":false,"given":"Tomasz","family":"Wybranowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-8614","authenticated-orcid":false,"given":"Marta","family":"Napi\u00f3rkowska-Mastalerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1004-7834","authenticated-orcid":false,"given":"Kamila","family":"Dybowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"\u017bekanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-6946","authenticated-orcid":false,"given":"Stefan","family":"Kruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8324-163X","authenticated-orcid":false,"given":"Grzegorz","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jinf.2025.106672_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jinf.2025.106672_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jinf.2020.08.021","article-title":"Serum cholinesterase associated with COVID-19 pneumonia severity and mortality","volume":"82","author":"Nakajima","year":"2021","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106672_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002280000259","article-title":"The effect of community-acquired pneumonia on plasma esterases in older people","volume":"57","author":"Abou-Hatab","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106672_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0019-5278.111755","article-title":"Assessment of acetylcholinesterase and butyrylcholinesterase activities in blood plasma of agriculture workers","volume":"16","author":"Dhananjayan","year":"2012","journal-title":"Indian J Occup Environ Med"},{"issue":"5","key":"10.1016\/j.jinf.2025.106672_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jinf.2025.106672_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jinf.2025.106672_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/QCO.0b013e32835ebc6d","article-title":"Long-term prognosis in community-acquired pneumonia","volume":"26","author":"Restrepo","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106672_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jinf.2025.106672_bib9","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"2013"},{"issue":"7","key":"10.1016\/j.jinf.2025.106672_bib10","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:33:39Z","timestamp":1781771619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325002725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0163445325002725"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106672","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Butyrylcholinesterase as an overlooked prognostic biomarker of 100-day mortality in non-COVID CAP","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106672"}}